India's Pharmaceutical Exports

Country Profile

Turkmenistan

Turkmenistan is an emerging destination for Indian pharmaceutical exports — $31.3M in FY 2025–26, with 1.5× growth over the past decade. Medicines accounts for 89% of shipments, with vaccines contributing $1.67M. The compound annual growth rate since FY2015 stands at 4.0%.

🇹🇲 $31.3M · 1.5× growth since FY2015 · 4.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$31.3M
Exports FY2025–26 DGCIS
1.5×
Growth FY2015→2026
4.0%
CAGR FY2015→2026
89%
Medicines Share
5
Product Categories Supplied
Turkmenistan is an emerging destination for Indian pharmaceutical exports — $31.3M in FY 2025–26, with 1.5× growth over the past decade. Medicines accounts for 89% of shipments, with vaccines contributing $1.67M. The compound annual growth rate since FY2015 stands at 4.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $27.9M (88.9%) Vaccines $1.67M (5.3%) Traditional & Herbal $1.07M (3.4%) Medicine Ingredients $624K (2.0%) Surgical & Hospital Supplies $110K (0.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Turkmenistan in the RBI overseas direct investment dataset (2011–2026).